U.S. FDA approves first nonprescription daily oral contraceptive


  • World
  • Friday, 14 Jul 2023

LOS ANGELES, July 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy, which is the first daily oral contraceptive approved for use in the United States without a prescription.

Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stores, convenience stores and grocery stores, as well as online.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

Canada's employment increases in November
Iraqi presidency denies knowledge of "terror" designation of Hezbollah, Houthis
Bolsonaro supports eldest son's presidential run next year
Trump says he will talk trade with leaders of Mexico, Canada at World Cup draw
Israeli gov't approves 2026 state budget at 205 bln USD
U.S. key inflation gauge remains elevated in September
Trump-backed Asfura keeps slim lead in Honduras election as US keeps close watch
Russia's gold reserves hit historical high of over 310 bln USD
Sierra Leone's Freetown to deepen trade, culture cooperation with China's Hefei
Moody's sees floods pose limited drag on Malaysia's economy

Others Also Read